A patient with prolonged paralysis

Clinical Chemistry

Volumn 58, Issue 3, 2012, Pages 496-500

  Whittington, JoDell E ^a   Pham, Hoai D ^b   Procter, Melinda ^c   Grenache, David G ^a,c   Mao, Rong ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUXAMETHONIUM; VECURONIUM;

ACUTE ABDOMEN; ACUTE APPENDICITIS; ADULT; ANAMNESIS; APPENDECTOMY; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DRUG HALF LIFE; ENDOTRACHEAL INTUBATION; FOLLOW UP; HUMAN; MALE; MUSCLE TWITCH; NUCLEOTIDE SEQUENCE; PARALYSIS; PHENOTYPE; SEDATION;

BASE SEQUENCE; BUTYRYLCHOLINESTERASE; HUMANS; MALE; MUTATION; PARALYSIS; PHENOTYPE; SEQUENCE ANALYSIS, DNA; SUCCINYLCHOLINE; YOUNG ADULT;

EID: 84857826162     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.163782     Document Type: Article

References (12)

1. Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 2003;4:131-8. (Pubitemid 37271383)
2. Primo-Parmo SL, Bartels CF, Wiersema B, van der Spek AF, Innis JW, La Du BN. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. Am J Hum Genet 1996;58:52-64.
3. Cokugras AN. Butyrylcholinesterase: structure and physiological importance. Turk J Biochem 2003;28:54-61.
4. Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers. Can J Biochem Physiol 1957;35:339-46.
5. Kalow W, Lindsay HA. A comparison of optical and manometric methods for the assay of human serum cholinesterase. Can J Biochem Physiol 1955;33: 568-74.
6. Lehmann H, Ryan E. The familial incidence of low pseudocholinesterase level. Lancet 1956;271:124.
7. Harris H, Whittaker M. Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes. Nature 1961; 191:496-8.
8. Hodgkin W, Giblett ER, Levine H, Bauer W, Motulsky AG. Complete pseudocholinesterase deficiency: genetic and immunologic characterization. J Clin Invest 1965;44:486-93.
9. Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T, La Du BN. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992;50: 1086-103.
10. Yen T, Nightingale BN, Burns JC, Sullivan DR, Stewart PM. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. Clin Chem 2003;49:1297-308. (Pubitemid 36900616)
11. De Jaco A, Comoletti D, Kovarik Z, Gaietta G, Radic Z, Lockridge O, et al. A mutation linked with autism reveals a common mechanism of endoplasmic reticulum retention for the alpha,beta-hydrolase fold protein family. J Biol Chem 2006;281:9667-76. (Pubitemid 43864685)
12. Parnas ML, Procter M, Schwarz MA, Mao R, Grenache DG. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting. Am J Clin Pathol 2011;135:271-6.